- Home
- STLD vs PODD Comparison
STLD vs PODD Comparison
Compare STLD & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STLD
- PODD
- Stock Information
- Founded
- STLD 1993
- PODD 2000
- Country
- STLD United States
- PODD United States
- Employees
- STLD N/A
- PODD N/A
- Industry
- STLD Steel/Iron Ore
- PODD Medical/Dental Instruments
- Sector
- STLD Industrials
- PODD Health Care
- Exchange
- STLD Nasdaq
- PODD Nasdaq
- Market Cap
- STLD 17.7B
- PODD 16.5B
- IPO Year
- STLD 1996
- PODD 2007
- Fundamental
- Price
- STLD $125.83
- PODD $275.81
- Analyst Decision
- STLD Buy
- PODD Buy
- Analyst Count
- STLD 12
- PODD 16
- Target Price
- STLD $138.42
- PODD $271.19
- AVG Volume (30 Days)
- STLD 1.6M
- PODD 533.0K
- Earning Date
- STLD 01-22-2025
- PODD 02-20-2025
- Dividend Yield
- STLD 1.46%
- PODD N/A
- EPS Growth
- STLD N/A
- PODD 235.68
- EPS
- STLD 11.07
- PODD 5.74
- Revenue
- STLD $17,901,675,000.00
- PODD $1,983,900,000.00
- Revenue This Year
- STLD N/A
- PODD $23.56
- Revenue Next Year
- STLD $1.32
- PODD $18.07
- P/E Ratio
- STLD $11.36
- PODD $48.09
- Revenue Growth
- STLD N/A
- PODD 27.42
- 52 Week Low
- STLD $104.60
- PODD $160.19
- 52 Week High
- STLD $155.56
- PODD $279.77
- Technical
- Relative Strength Index (RSI)
- STLD 55.99
- PODD 61.05
- Support Level
- STLD $114.81
- PODD $260.84
- Resistance Level
- STLD $126.96
- PODD $274.45
- Average True Range (ATR)
- STLD 3.26
- PODD 7.44
- MACD
- STLD 1.97
- PODD 0.65
- Stochastic Oscillator
- STLD 88.81
- PODD 88.34
About STLD Steel Dynamics Inc.
Steel Dynamics Inc operates scrap-based steel minimills with roughly 16 million tons of annual steel production capacity. The company's segment includes steel operations, metals recycling operations, steel fabrication operations, Aluminum Operations Segment, and others. It generates maximum revenue from the steel operations segment.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.